Surmodics Inc Forecast, price target & analysts
Surmodics Inc Target price 2025 - Analyst rating & recommendation
Surmodics Inc Classifications & Recommendation:
Surmodics Inc Price Target
| Target Price | $43.86 |
| Price | $42.98 |
| Potential |
2.05%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Surmodics Inc 2026 .
The average Surmodics Inc target price is $43.86.
This is
2.05%
register free of charge
$45.15
5.05%
register free of charge
$43.43
1.05%
register free of charge
|
|
| A rating was issued by 7 analysts: 0 Analysts recommend Surmodics Inc to buy, 4 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Surmodics Inc stock has an average upside potential 2026 of
2.05%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 126.08 | 120.08 |
| 4.90% | 4.76% | |
| EBITDA Margin | 1.24% | 9.02% |
| 83.55% | 629.00% | |
| Net Margin | -9.15% | -3.52% |
| 687.98% | 61.54% |
4 Analysts have issued a sales forecast Surmodics Inc 2025 . The average Surmodics Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Surmodics Inc EBITDA forecast 2025. The average Surmodics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Surmodics Inc Analysts have issued a net profit forecast 2025. The average Surmodics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.82 | -0.30 |
| 645.45% | 63.41% |
4 Analysts have issued a Surmodics Inc forecast for earnings per share. The average Surmodics Inc EPS is
This results in the following potential growth metrics and future valuations:
P/E ratio
| Current |
|---|
Current Surmodics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barrington Research |
Locked
➜
Locked
|
Locked | Nov 14 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jan 30 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barrington Research:
Locked
➜
Locked
|
Nov 14 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Mar 07 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jan 30 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Nov 07 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
